| Condition Type | Endocrine (hormonal) disorder |
| Affected System | Hypothalamic-pituitary-gonadal (HPG) axis |
| Common Diagnostic Threshold | Total serum testosterone below ~300 ng/dL (American Urological Association guidelines) |
| Estimated US Prevalence | Affects an estimated 2–6 million men in the US (Endocrine Society clinical data) |
| Key Diagnostic Tests | Morning serum testosterone (×2), LH, FSH, prolactin, SHBG |
| Main Treatment Categories | TRT, gonadotropin therapy, treating underlying cause |
What Is Male Hypogonadism?
Male hypogonadism is a clinical condition in which the testes produce insufficient testosterone, sperm, or both. The term comes from the Greek root for "seed" — reflecting the testes' dual role in hormone production and fertility. It is not simply a byproduct of aging, though age-related testosterone decline does exist. True hypogonadism involves a measurable hormonal deficit tied to dysfunction in the testes, the pituitary gland, or the hypothalamus.
| Condition Type | Endocrine (hormonal) disorder |
| Affected System | Hypothalamic-pituitary-gonadal (HPG) axis |
| Common Diagnostic Threshold | Total serum testosterone below ~300 ng/dL (American Urological Association guidelines) |
| Estimated US Prevalence | Affects an estimated 2–6 million men in the US (Endocrine Society clinical data) |
| Key Diagnostic Tests | Morning serum testosterone (×2), LH, FSH, prolactin, SHBG |
| Main Treatment Categories | TRT, gonadotropin therapy, treating underlying cause |
Clinicians classify hypogonadism by its origin:
- Primary hypogonadism originates in the testes themselves. The testes fail to produce adequate testosterone even when the brain sends appropriate hormonal signals.
- Secondary (central) hypogonadism stems from insufficient signaling from the hypothalamus or pituitary gland, which normally stimulate testicular function via luteinizing hormone (LH) and follicle-stimulating hormone (FSH).
- Mixed hypogonadism involves dysfunction at multiple levels and is more common in older men.
For broader context on how testosterone naturally shifts throughout a man's life, see how testosterone changes across the lifespan.
Hypogonadism
A clinical condition in which the gonads (testes in men) produce insufficient sex hormones, sperm, or both. Diagnosis requires confirmed low hormone levels alongside consistent symptoms.
Testosterone
The primary male sex hormone produced mainly in the testes. It regulates libido, muscle mass, bone density, red blood cell production, and mood.
LH (Luteinizing Hormone)
A hormone released by the pituitary gland that signals the testes to produce testosterone. Abnormal LH levels help distinguish primary from secondary hypogonadism.
Primary vs. Secondary Hypogonadism
Primary hypogonadism originates in the testes; secondary originates in the pituitary or hypothalamus. The distinction determines the appropriate diagnostic workup and treatment approach.
SHBG (Sex Hormone-Binding Globulin)
A protein that binds testosterone in the bloodstream, making it unavailable to tissues. High SHBG can reduce the amount of biologically active (free) testosterone even when total testosterone appears normal.
TRT (Testosterone Replacement Therapy)
A medically supervised treatment that delivers exogenous testosterone to restore levels in men with confirmed hypogonadism. Available in multiple forms including gels, injections, and implants.
Common Causes and Risk Factors
The root causes of hypogonadism vary significantly depending on whether the problem originates in the testes or the brain's signaling centers.
Primary Causes
- Klinefelter syndrome — a congenital condition (XXY chromosomes) that impairs testicular development
- Undescended testes (cryptorchidism) left untreated in childhood
- Testicular injury or trauma
- Chemotherapy or radiation affecting the testes
- Mumps orchitis — viral inflammation of the testes
Secondary Causes
- Pituitary tumors or structural abnormalities disrupting LH and FSH release
- Kallmann syndrome — a genetic condition causing GnRH deficiency
- Hemochromatosis — excess iron deposits in the pituitary or testes
- Use of opioids, anabolic steroids, or certain medications that suppress the hypothalamic-pituitary axis
- Obesity, which can lower testosterone through increased conversion to estrogen in fat tissue
Lifestyle and systemic factors — including chronic illness, obstructive sleep apnea, and severe psychological stress — can contribute as well. Research consistently links poor sleep quality to suppressed testosterone; sleep and men's hormone disruption is an often-underestimated connection.
Recognizing Symptoms and Getting Diagnosed
Symptoms of hypogonadism vary in severity and are nonspecific — meaning they overlap with many other conditions. Common presentations include:
- Reduced libido and erectile dysfunction
- Fatigue and decreased energy
- Loss of muscle mass and increased body fat
- Mood changes, including depression or irritability
- Decreased bone density (osteopenia or osteoporosis over time)
- Reduced body and facial hair
- Infertility
Symptoms Alone Cannot Confirm Hypogonadism
Fatigue, low libido, and mood changes are common and can have many causes unrelated to testosterone. Clinical guidelines require at least two separate morning blood tests confirming low testosterone before a diagnosis is made. Self-diagnosis or self-treatment without medical supervision carries real risks, including worsening of the underlying condition and fertility impairment.
Diagnosis requires laboratory confirmation. Clinicians typically measure serum total testosterone on at least two separate morning samples (when testosterone peaks). Reference ranges vary by laboratory, but most guidelines define low testosterone as a total serum level below approximately 300 ng/dL, paired with consistent symptoms. LH, FSH, prolactin, and sex hormone-binding globulin (SHBG) levels are also assessed to determine the type and likely cause. A complete workup may include imaging of the pituitary gland if secondary hypogonadism is suspected.
Because testosterone is not the only driver of male hormonal health, a thorough evaluation looks at the full clinical picture — not a single number.
Treatment Pathways and Ongoing Management
Treatment depends on the underlying cause, the man's goals (including whether fertility preservation matters), and overall health status. General pathways include:
Testosterone Replacement Therapy (TRT)
TRT is the most common approach for men who are not seeking to preserve fertility. It is available in several forms — topical gels, injections, transdermal patches, buccal systems, and subcutaneous pellets. Each has different absorption profiles, dosing schedules, and potential side effects. The choice is made collaboratively between patient and clinician based on preference and clinical factors.
Gonadotropin Therapy
For men with secondary hypogonadism who wish to maintain or restore fertility, injections of LH-analog (hCG) and sometimes FSH can stimulate the testes directly without suppressing natural sperm production the way TRT does.
Treating the Underlying Cause
When hypogonadism is secondary to another condition — such as a pituitary tumor, hemochromatosis, or medication use — addressing that root cause may partially or fully restore testosterone levels.
Lifestyle Modification
Weight loss, resistance exercise, and sleep improvement can meaningfully raise testosterone in men whose low levels are partly driven by obesity or lifestyle factors. These changes are typically recommended alongside, not instead of, clinical treatment.
Men with coexisting prostate concerns should discuss treatment options carefully with their clinician; see prostate health considerations by decade for relevant context. All treatment decisions must be made in partnership with a qualified healthcare provider.
This article is for general informational purposes only and does not constitute medical advice. If you have symptoms that concern you, consult a licensed healthcare professional for proper evaluation and personalized guidance.
